We are live on ! Find out more
INBX

Inhibrx, Inc. Common Stock
INBX

Delisted

INBX was delisted on the 29th of May, 2024.

Back to rankings

100 hedge funds and large institutions have $297M invested in Inhibrx, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 40 increasing their positions, 25 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

24,400% more call options, than puts

Call options by funds: $245K | Put options by funds: $1K

60% more repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 25

29% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 14

1% more funds holding

Funds holding: 99 → 100 (+1)

46% less capital invested

Capital invested by funds: $548M → $297M (-$251M)

Holders
100
Holders Change
+1
Holders Change %
+1.01%
% of All Funds
1.68%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
18
Increased
40
Reduced
25
Closed
14
Calls
$245K
Puts
$1K
Net Calls
+$244K
Net Calls Change
-$2.68M

Top Buyers

Rank Fund Capital Flow
1
MB
MPM BioImpact
Massachusetts
+$15.1M
2
Millennium Management
Millennium Management
New York
+$13.9M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
+$10.3M
4
OM
Opaleye Management
Massachusetts
+$8.68M
5
Wellington Management Group
Wellington Management Group
Massachusetts
+$4.47M

Top Sellers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$25.7M
2
State Street
State Street
Massachusetts
-$15.6M
3
TLP
Tri Locum Partners
New York
-$9.06M
4
SI
Sofinnova Investments
California
-$5.39M
5
Morgan Stanley
Morgan Stanley
New York
-$2.12M
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
26
Morgan Stanley
New York
$1.59M -$2.12M -144,068 -51%
LNWWM
27
Laird Norton Wetherby Wealth Management
California
$1.56M +$1.54K +105 +0.1%
Two Sigma Investments
28
Two Sigma Investments
New York
$1.41M +$978K +66,452 +115%
MWA
29
Meridian Wealth Advisors
Texas
$1.39M – – –
D.E. Shaw & Co
30
D.E. Shaw & Co
New York
$1.37M +$1.25M +85,016 +236%
N
31
Nuveen
North Carolina
$1.31M +$476K +32,388 +39%
Verition Fund Management
32
Verition Fund Management
Connecticut
$1.08M +$1.4M +95,076 New
Victory Capital Management
33
Victory Capital Management
Texas
$1.01M -$160K -10,891 -11%
UOC
34
UBS O'Connor
Illinois
$965K +$1.25M +85,050 New
Bank of New York Mellon
35
Bank of New York Mellon
New York
$938K -$50.4K -3,427 -4%
Goldman Sachs
36
Goldman Sachs
New York
$914K -$942K -64,032 -44%
Squarepoint
37
Squarepoint
New York
$877K +$967K +65,757 +571%
BG
38
Bellevue Group
Switzerland
$869K +$396K +26,900 +54%
BC
39
Birchview Capital
Vermont
$800K +$294K +20,000 +40%
Walleye Capital
40
Walleye Capital
New York
$773K -$624K -42,394 -38%
ECM
41
ExodusPoint Capital Management
New York
$763K +$989K +67,233 New
CSS
42
Cubist Systematic Strategies
Connecticut
$685K +$675K +45,896 +317%
Swiss National Bank
43
Swiss National Bank
Switzerland
$608K +$458K +31,100 +138%
IC
44
Ikarian Capital
Texas
$561K -$1.6M -108,470 -69%
Citadel Advisors
45
Citadel Advisors
Florida
$506K -$1.43M -96,933 -69%
Two Sigma Advisers
46
Two Sigma Advisers
New York
$502K +$406K +27,600 +166%
Qube Research & Technologies (QRT)
47
Qube Research & Technologies (QRT)
United Kingdom
$453K +$587K +39,875 New
M&T Bank
48
M&T Bank
New York
$376K +$315K +21,429 +182%
RhumbLine Advisers
49
RhumbLine Advisers
Massachusetts
$373K +$65.2K +4,435 +16%
California State Teachers Retirement System (CalSTRS)
50
California State Teachers Retirement System (CalSTRS)
California
$361K +$166K +11,285 +55%
1
2
3 4 5

INBX Hedge Fund Activity: Q2 2022 in Review

100 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Inhibrx, Inc. Common Stock (INBX) for Q2 2022, worth a combined $297M — down 46% from $548M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new INBX positions and 14 closed out — a net gain of 4 holders — while 40 added to existing stakes and 25 trimmed.

The largest buyer was MPM BioImpact, opening a new position worth an estimated $15.1M. The largest seller was Adage Capital Partners, exiting entirely with an estimated $25.7M sold.

  • 100 institutional investors held Inhibrx, Inc. Common Stock (INBX) as of Q2 2022, up from 99 in Q1 2022.
  • Funds reported $297M of Inhibrx, Inc. Common Stock stock for Q2 2022, down 46% quarter-over-quarter.
  • 18 funds opened new Inhibrx, Inc. Common Stock positions in Q2 2022 and 14 closed out, a net change of +4 holders.
  • The largest Inhibrx, Inc. Common Stock buyer in Q2 2022 was MPM BioImpact, an estimated $15.1M added.
  • The largest Inhibrx, Inc. Common Stock seller in Q2 2022 was Adage Capital Partners, an estimated $25.7M sold.

Based on aggregated 13F filings for Q2 2022.